Control of CD8α transcription during development of α/β T cell receptor (TCR) T lymphocytes is mediated by at least two distinct stage-specific cis-acting transcriptional mechanisms (i.e., enhancers). On the CD8α−/−knockout (KO) background, cis-mechanism I and cis-mechanism II together mediate appropriate stage- and sublineage-specific transgenic (Tg) CD8α expression and “rescue” development of peripheral CD8+ single-positive (SP) cytotoxic T lymphocytes (CTLs). In contrast, on the wild-type (WT)/CD8+/+ or CD8α−/−KO backgrounds, a CD8α Tg directed by cis-mechanism I alone is activated during the double negative [DN] to double positive [DP] transition and expressed up to the CD3low/intermediate DP stage but not in more mature DP or SP thymocytes or peripheral T cells. As loss of cis mechanism I activity occurs around the onset of positive selection, it is possible that events associated with TCR/major histocompatibility complex (MHC) interactions and selection are involved in initiating these changes in CD8α transcription. To examine this issue, phenotypic and functional studies were performed for thymocytes and T cells of CD8α−/−KO mice that expressed a CD8α Tg under control of cis-mechanism I only. Despite loss of CD8α expression at the DP CD3low/intermediate stage, increased populations of mature CD3hiCD4−CD8− thymocytes and CD3+CD4−CD8− peripheral T cells were detected. By several criteria, including MHC class I–restricted antigen recognition, these cells have at least partially undergone positive and negative selection. Therefore, initiation of selection and sublineage commitment are determined before loss of cis-mechanism I–mediated control of CD8α transcription. Further, CD8 expression beyond the CD3low/intermediate DP thymic stage is not essential for CTL development in vivo or function.
Skip Nav Destination
Article navigation
3 September 2001
Article Contents
Brief Definitive Report|
September 04 2001
Cd8 Expression up to the Double-Positive CD3Low/Intermediate Stage of Thymic Differentiation Is Sufficient for Development of Peripheral Functional Cytotoxic T Lymphocytes
X.-L. Zhang,
X.-L. Zhang
aResearch Institute, Program in Infection, Immunity, Injury and Repair, The Hospital for Sick Children,
Search for other works by this author on:
S. Zhao,
S. Zhao
aResearch Institute, Program in Infection, Immunity, Injury and Repair, The Hospital for Sick Children,
Search for other works by this author on:
S.H. Borenstein,
S.H. Borenstein
aResearch Institute, Program in Infection, Immunity, Injury and Repair, The Hospital for Sick Children,
cInstitute of Medical Science, University of Toronto, Toronto, Ontario M5G 1X8, Canada
Search for other works by this author on:
Y. Liu,
Y. Liu
aResearch Institute, Program in Infection, Immunity, Injury and Repair, The Hospital for Sick Children,
Search for other works by this author on:
B. Jayabalasingham,
B. Jayabalasingham
aResearch Institute, Program in Infection, Immunity, Injury and Repair, The Hospital for Sick Children,
bDepartment of Immunology, University of Toronto, Toronto, Ontario M5G 1X8, Canada
Search for other works by this author on:
J.W. Chamberlain
J.W. Chamberlain
aResearch Institute, Program in Infection, Immunity, Injury and Repair, The Hospital for Sick Children,
bDepartment of Immunology, University of Toronto, Toronto, Ontario M5G 1X8, Canada
cInstitute of Medical Science, University of Toronto, Toronto, Ontario M5G 1X8, Canada
Search for other works by this author on:
X.-L. Zhang
aResearch Institute, Program in Infection, Immunity, Injury and Repair, The Hospital for Sick Children,
S. Zhao
aResearch Institute, Program in Infection, Immunity, Injury and Repair, The Hospital for Sick Children,
S.H. Borenstein
aResearch Institute, Program in Infection, Immunity, Injury and Repair, The Hospital for Sick Children,
cInstitute of Medical Science, University of Toronto, Toronto, Ontario M5G 1X8, Canada
Y. Liu
aResearch Institute, Program in Infection, Immunity, Injury and Repair, The Hospital for Sick Children,
B. Jayabalasingham
aResearch Institute, Program in Infection, Immunity, Injury and Repair, The Hospital for Sick Children,
bDepartment of Immunology, University of Toronto, Toronto, Ontario M5G 1X8, Canada
J.W. Chamberlain
aResearch Institute, Program in Infection, Immunity, Injury and Repair, The Hospital for Sick Children,
bDepartment of Immunology, University of Toronto, Toronto, Ontario M5G 1X8, Canada
cInstitute of Medical Science, University of Toronto, Toronto, Ontario M5G 1X8, Canada
X.-L. Zhang and S. Zhao contributed equally to this work.
Received:
March 19 2001
Revision Requested:
June 20 2001
Accepted:
July 16 2001
Online ISSN: 1540-9538
Print ISSN: 0022-1007
© 2001 The Rockefeller University Press
2001
The Rockefeller University Press
J Exp Med (2001) 194 (5): 685–694.
Article history
Received:
March 19 2001
Revision Requested:
June 20 2001
Accepted:
July 16 2001
Citation
X.-L. Zhang, S. Zhao, S.H. Borenstein, Y. Liu, B. Jayabalasingham, J.W. Chamberlain; Cd8 Expression up to the Double-Positive CD3Low/Intermediate Stage of Thymic Differentiation Is Sufficient for Development of Peripheral Functional Cytotoxic T Lymphocytes. J Exp Med 3 September 2001; 194 (5): 685–694. doi: https://doi.org/10.1084/jem.194.5.685
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement